Liu, Yuwang <br/><br/>
Pharmacokinetics and safety of nifedipine GITS/candesartan fixed-dose combination in subjects with hepatic impairment
.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Mar 2017 
 - 246-255 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/CP202700  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--administration & dosage<br/>Antihypertensive Agents--administration & dosage<br/>Area Under Curve<br/>Calcium Channel Blockers--administration & dosage<br/>Drug Combinations<br/>Female<br/>Germany<br/>Half-Life<br/>Humans<br/>Liver--metabolism<br/>Liver Diseases--diagnosis<br/>Liver Function Tests<br/>Male<br/>Metabolic Clearance Rate<br/>Middle Aged<br/>Nifedipine--administration & dosage<br/>Severity of Illness Index<br/>Tablets<br/>Vasodilator Agents--administration & dosage